Medtronic

Medtronic manufactures a broad range of implantable and wearable medical devices alongside networked programming and remote-monitoring platforms that connect directly to patient care workflows, creating a high-stakes attack surface where vulnerabilities can affect clinical safety and device integrity. The vendor's vulnerability portfolio, while modest in volume, concentrates in its CardiLink remote-management ecosystem and ValleyLab surgical energy platforms, with recurring weakness classes centered on authentication gaps, access-control deficiencies, and cleartext transmission of sensitive data—exposures particularly concerning in medical-device contexts where operational integrity and patient privacy are interdependent. A meaningful share of the vendor's disclosures reach serious severity, reflecting the control and data-access implications of networked medical infrastructure. Defenders should prioritize inventory and segmentation of Medtronic networked devices, coordinate updates through clinical engineering channels, and treat authentication and encryption gaps in these products as high-risk even when exploit activity is not the primary concern. Current exploitation activity and exposure counts are shown alongside this summary.